Cool! The USA FDA Has Approved The First Drug That Can Relieve Depression In Hours Instead Of Weeks. The Drug, Esketamine, Marketed As Spravato, Is A Chemical Cousin Of Ketamine. Esketamine Will Be Administered In Approved Treatment Centers Via Nasal Spray, And Each Treatment Could Cost from $590 to $885 Depending On The Dose.
Ketamine-Derived Drug Spravato For Major Depression Gets FDA Approval : Shots – Health News : NPR
Three decades after Prozac arrived, consumers are getting a new kind of antidepressant. The medicine is based on the anesthetic ketamine, which has been used illicitly as a party drug.